Saketh S. Dinavahi

Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents

Saketh S. Dinavahi, Raghavendra Gowda, Christopher G. Bazewicz et al. · European Journal of Medicinal Chemistry · 2019 · 41 citations · Full text

Medicinal Chemistry, Synthesis Characterization, Biochemistry +9

Nanoliposomal delivery of cytosolic phospholipase A2 inhibitor arachidonyl trimethyl ketone for melanoma treatment

Raghavendra Gowda, Saketh S. Dinavahi, Soumya Iyer et al. · Nanomedicine Nanotechnology Biology and Medicine · 2018 · 30 citations · Full text

Nanomedicine, Engineering, Melanoma Treatment +6

Development of a Novel Multi-Isoform ALDH Inhibitor Effective as an Antimelanoma Agent

Saketh S. Dinavahi, Raghavendra Gowda, Krishne Gowda et al. · Molecular Cancer Therapeutics · 2019 · 29 citations · Full text

Targeting WEE1/AKT Restores p53-Dependent Natural Killer–Cell Activation to Induce Immune Checkpoint Blockade Responses in “Cold” Melanoma

Saketh S. Dinavahi, Yu‐Chi Chen, Kishore Punnath et al. · Cancer Immunology Research · 2022 · 29 citations · Full text

Stress Ligands, Immunology, Immune Regulation +17

Identifying the structure-activity relationship of leelamine necessary for inhibiting intracellular cholesterol transport

Raghavendra Gowda, Gajanan S. Inamdar, Omer F. Kuzu et al. · Oncotarget · 2017 · 28 citations · Full text

Lipid Movement, Pharmaceutical Chemistry, Tumor Biology +16